Ex-Valeant Official's Trial Set to Revive Its Past Pain
- Former director Gary Tanner accused of taking kickbacks
- He goes on trial with ex-pharmacy CEO Andrew Davenport
Valeant Pharmaceuticals headquarters stands in Bridgewater Township, New Jersey.
Photographer: Michael Nagle/Bloomberg
This article is for subscribers only.
The legal woes that caused investors to flee Valeant Pharmaceuticals International Inc. a few years back are about to be publicly dissected for the first time as a former executive accused in a multimillion-dollar fraud goes on trial in Manhattan.
Federal prosecutors allege Gary Tanner, a onetime senior director at Valeant, conspired with Andrew Davenport, the ex-chief executive officer of a mail-order pharmacy, to secretly steer the drugmaker’s business to the retailer in exchange for massive financial kickbacks.